Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin etoposide for stage III non-small-cell lung cancer. A randomized study - Jeremic,B.; Shibamoto,Y.; Acimovic,L.; Milisavljevic,S. (J Clin Oncol, 1996)